Medtronic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Medtronic 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MDT
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.
CEOGeoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees95,000
Employees95,000
HeadquartersGalway, Galway
HeadquartersGalway, Galway
Founded2014
Founded2014
Employees95,000
Employees95,000
MDT Key Statistics
Market cap107.91B
Market cap107.91B
Price-Earnings ratio25.58
Price-Earnings ratio25.58
Dividend yield3.33%
Dividend yield3.33%
Average volume6.13M
Average volume6.13M
High today$84.78
High today$84.78
Low today$83.50
Low today$83.50
Open price$84.39
Open price$84.39
Volume5.88M
Volume5.88M
52 Week high$96.25
52 Week high$96.25
52 Week low$75.96
52 Week low$75.96
MDT News
TipRanks 12h
Medtronic announces Expand URO IDE study met primary safety, effective endpointMedtronic (MDT) announced that the Expand URO Investigational Device Exemption , IDE, clinical study, the largest such study for robotic-assisted urologic surge...
TipRanks 12h
Medtronic announces outcomes from two studies in AFib patientsMedtronic (MDT) announced positive clinical outcomes from two studies in atrial fibrillation, AFib, patients treated with the Affera family of technologies, inc...
Seeking Alpha 2d
Medtronic seeks FDA nod for Hugo robotic surgery systemMedtronic (NYSE:MDT) confirmed on Saturday the submission of regulatory filings with the FDA to obtain marketing approval for its Hugo robotic-assisted surgery...
Analyst ratings
47%
of 32 ratingsBuy
46.9%
Hold
43.8%
Sell
9.4%
More MDT News
Simply Wall St 2d
Medtronic Secures FDA Approval For Innovative OmniaSecure Defibrillation Leadrecently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in cardiovascular technology, along with results from its LEA...